Related Experiment Video

Updated: May 6, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.4K

Pasteurella multocida peritonitis in hepatic cirrhosis with ascites

D N Gerding, M Y Khan, J W Ewing

    Gastroenterology
    |March 1, 1976
    PubMed

    Insights

    Pasteurella multocida peritonitis can occur spontaneously in cirrhosis patients with ascites and animal contact. This rare infection, often linked to cats, can be fatal, highlighting the need for clinical consideration.

    Area of Science:

    • Infectious Diseases
    • Hepatology

    Background:

    • Cirrhosis and ascites create a vulnerable state for spontaneous bacterial peritonitis.
    • Pasteurella multocida is a bacterium commonly found in domestic animals.

    Observation:

    • Two cases of spontaneous Pasteurella multocida peritonitis in patients with cirrhosis and ascites are presented.
    • Both patients had significant contact with domestic animals, though no bites were reported.
    • One patient died due to the infection, while the other succumbed to unrelated causes.

    Findings:

    • This study highlights a rare but serious association between Pasteurella multocida peritonitis and cirrhosis with ascites.
    • The organism was identified as a cause of spontaneous peritonitis in cirrhotic patients with animal exposure.
    • A previous report documented only one similar case, underscoring the rarity.

    Implications:

    • Pasteurella multocida should be considered in the differential diagnosis of peritonitis in cirrhotic patients, especially those with animal contact.
    • Clinicians should inquire about animal exposure in cirrhotic patients presenting with peritonitis.
    • Early recognition and treatment may be crucial for improving outcomes in these patients.

    More Related Videos

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats09:37

    Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

    Published on: August 1, 2018

    14.4K
    Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection07:38

    Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

    Published on: May 10, 2024

    1.7K

    Related Concept Videos

    Pleural Effusion II: Symptoms and Management01:28

    Pleural Effusion II: Symptoms and Management

    Pleural Effusion Overview
    A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
    Clinical Manifestations:
    1.4K
    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
    53
    Portal Hypertension01:22

    Portal Hypertension

    Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
    58
    Ascites01:19

    Ascites

    DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
    54
    Hepatic Encephalopathy01:29

    Hepatic Encephalopathy

    DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
    71
    Cholecystitis01:20

    Cholecystitis

    Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
    33